NUTM1 and thyroid gland carcinoma: For instance, in our network, six TFs with an activation domain bound to the promoter of NUTM1, which are frequently rearranged or fused with other genes and whose overexpression is associated with poor prognosis in patients with NUT carcinoma (French 2018), B-cell precursor acute lymphoblastic leukemia (Hormann et al, 2019), oral squamous cell carcinoma (OSCC) (Riaz & Khan 2023Preprint), and thyroid carcinoma (Allison et al, 2022).